Bafna Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	34.33	13.96	78.09	1.73	18.04
Cash & Short-Term Investments	2.54	34.33	13.96	78.09	1.73	18.04
Cash Growth	-80.65%	145.90%	-82.12%	4414.10%	-90.41%	-78.73%
Accounts Receivable	-	401.74	453.95	411.49	147.8	95.6
Other Receivables	-	-	-	-	-	109.7
Receivables	-	401.97	454.77	412.03	148.76	205.3
Inventory	-	280.86	296.42	222.2	202.81	154.43
Prepaid Expenses	-	5.21	4.61	3.73	-	2.34
Other Current Assets	-	139.43	167.95	157.07	155.5	116.57
Total Current Assets	-	861.79	937.71	873.12	508.8	496.68
Property, Plant & Equipment	-	660.93	507.07	402.3	388.46	367.98
Long-Term Investments	-	0.01	-	-	-	-
Other Intangible Assets	-	-	17.7	15	-	-
Other Long-Term Assets	-	8.07	14.34	5.42	4.19	-
Total Assets	-	1,531	1,477	1,296	901.45	864.66
Accounts Payable	-	309.45	354.22	284.61	124.05	106.92
Accrued Expenses	-	32.22	30.19	27.38	33.39	21.5
Short-Term Debt	-	85.7	100.11	119.09	45.92	100
Current Portion of Long-Term Debt	-	56	36.25	25.81	11.51	5
Current Income Taxes Payable	-	-	-	0.81	0.9	-
Current Unearned Revenue	-	1.66	0.99	0.99	0.66	-
Other Current Liabilities	-	33.49	19.07	6.07	3.71	9.67
Total Current Liabilities	-	518.52	540.83	464.76	220.13	243.09
Long-Term Debt	-	140.29	107.53	84.33	53.17	52.86
Long-Term Unearned Revenue	-	19.14	16.15	12.19	8.51	-
Other Long-Term Liabilities	-	4.78	3.92	-	-	1
Total Liabilities	-	682.73	668.43	561.29	281.81	296.95
Common Stock	-	236.56	236.56	236.56	236.56	236.56
Additional Paid-In Capital	-	753.77	753.77	753.77	753.77	753.77
Retained Earnings	-	-412.08	-451.75	-525.6	-640.51	-692.43
Comprehensive Income & Other	-	269.81	269.81	269.81	269.81	269.81
Total Common Equity	912.28	848.07	808.39	734.55	619.64	567.71
Shareholders' Equity	912.28	848.07	808.39	734.55	619.64	567.71
Total Liabilities & Equity	-	1,531	1,477	1,296	901.45	864.66
Total Debt	324.03	281.99	243.89	229.24	110.59	157.86
Net Cash (Debt)	-321.48	-247.66	-229.93	-151.15	-108.86	-139.82
Net Cash Per Share	-13.60	-10.47	-9.72	-6.39	-4.60	-5.90
Filing Date Shares Outstanding	23.55	23.66	23.66	23.66	23.66	23.66
Total Common Shares Outstanding	23.55	23.66	23.66	23.66	23.66	23.66
Working Capital	-	343.27	396.88	408.35	288.67	253.59
Book Value Per Share	38.54	35.85	34.17	31.05	26.19	24.00
Tangible Book Value	912.28	848.07	790.69	719.55	619.64	567.71
Tangible Book Value Per Share	38.54	35.85	33.42	30.42	26.19	24.00
Land	-	1.93	1.93	1.93	1.93	1.93
Buildings	-	275.1	251.51	250.78	245.71	225.35
Machinery	-	778.25	741.42	693.86	631.75	568.38
Construction In Progress	-	73.13	104.96	-	-	8.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.